
姓名:刘永强
副研究员、中药学硕士生导师
简介:博士、硕士生导师。主要从事肿瘤靶向治疗与中药抗肿瘤作用机制研究,主持各类科研课题7项,在British Journal of Pharmacology、Pharmacological Research、PhytomedicineCell Reports Medicine与Neuro-Oncology等期刊发表论文40余篇,获2024年度广东省传统医学会科技进步奖二等奖(排名第三),担任广东省药理学会海洋药物药理专委会委员。
教育经历
[1] 2009.9-2013.12中国科学院动物研究所-博士
[2] 2007.9-2009.9中国科学院广州生物医药与健康研究院-硕转博
[3] 2003.9-2007.6山东师范大学-学士
工作经历
[1] 2020.8-至今,PP电子游戏网站PP电子游戏网站-副研究员
[2] 2017.7-2020.7,PP电子游戏网站科技创新中心-副研究员
[3] 2014.11-2017.6 美国福克斯蔡司癌症研究中心-博士后
研究方向:[1]中药抗肿瘤药理;[2]肿瘤免疫与靶向治疗研究。
研究领域:抗肿瘤药物药理
联系方式:liuyq@gzucm.edu.cn
研究课题
[1] PP电子游戏网站2024年青年拔尖人才(团队)“揭榜挂帅”项目(团队项目),2024.06-2027.06,50万元,主持。
[2] 2025年度中药学学科“固本”工程一级学科能力提升项目,GZY2025GB0734,髓母细胞瘤肿瘤微环境介导化疗耐药机制及中药靶向治疗策略研究,2025.07-2026.06,10万元,主持。
[3] 2025年度岭南中药资源教育部重点实验室开放课题,化橘红预防烟草致癌物诱导肺癌发生的药效评价与作用机制研究,2025.09-2026. 08,3万元,主持。
[4] 广东省自然科学基金面上项目,2022A1515011881,化橘红有效成分通过靶向Skp2-SCF E3连接酶治疗非小细胞肺癌的作用机制研究,2022.01-2024.12,10万元,主持,结题。
[5] 广东省区域联合基金地区培育项目,2021B1515140052,基于Fanconi anemia通路介导化疗耐药研究鹅不食草及其有效成分联合顺铂治疗肺癌的作用机制,2021.10-2024.09,30万元,主持,结题。
[6] 国家自然科学基金青年项目,81802776,小胶质细胞通过分泌IL-1β招募星形胶质细胞进而促进髓母细胞瘤发生的分子机理研究, 2019.01-2021.12,21万元,主持,结题。
代表性论文论著
[1] Yan-Chun Pang#, Chi Wang#, Jun-Feng Qiu#, …, Hailong Liu*, Yong-Qiang Liu*. Targeting tumor-associated macrophages-induced IGF1/PI3K/Zic1 axis triggers SHH medulloblastoma regression and chemosensitization. Neuro-Oncology. 2026. (Accepted, IF:13.4,中科院医学一区TOP期刊)
[2] Guo-Sheng Lin#, Rou-Qiao Zheng#, …, Youliang Xie*, Huicai Huang*, Yong-Qiang Liu*. Proteomic screening identifies brusatol targets TGFβRII to suppresses non-small cell lung cancer metastasis. Phytomedicine. 2025, 139: 156468.(IF:8.3,中科院一区)
[3] Hailong Liu#, …, Jiankang Li*, Yong-qiang Liu*, Xiaoguang Qiu*, Tao Jiang*. High cellular plasticity state of medulloblastoma local recurrence and distant dissemination. Cell Reports Medicine. 2025, 6: 101914.(IF:10.6,中科院一区)
[4] Han-Chen Wang#, Pei-En Wu#, …, Yong-Xian Cheng*, Yong-Qiang Liu*. Centipeda minima extracts and the active sesquiterpene lactones have therapeutic efficacy in non-small cell lung cancer by suppressing Skp2/p27 signaling pathway. Journal of Ethnopharmacology. 2025; 340: 119277. (IF:5.4,中科院一区)
[5] Yu-Fei Chen#, Yan-Chun Pang#, …, Xiang-Zhen Fan*, Yong-Xian Cheng*, Yong-Qiang Liu*. Identification of arnicolide C as a novel chemosensitizer to suppress mTOR/E2F1/FANCD2 axis in non-small cell lung cancer. British Journal of Pharmacology. 2024, 181:1221–1237.(IF:6.8,中科院二区)
[6] Da Huang#, …, Hui Xu*, Yong-Qiang Liu*. Ethanol Extract of Citrus grandis ‘Tomentosa’ Exerts Anticancer Effects by Targeting Skp2/p27 Pathway in Non-Small Cell Lung Cancer. Molecular Nutrition & Food Research, 2023, 67(18): 2300061.(IF:5.2,中科院二区)
[7] Yong-Qiang Liu*, Guang-Biao Zhou*. Promising anticancer activities and mechanisms of action of active compounds from the medicinal herb Centipeda minima (L.) A. Braun & Asch. Phytomedicine, 2022, 106: 154397.(IF:6.7,中科院一区)
[8] Shangping Xing#, …, Yong-Qiang Liu*. Brusatol has therapeutic efficacy in non-small cell lung cancer by targeting Skp1 to inhibit cancer growth and metastasis. Pharmacological Research, 2022, 176: 106059.(IF:10.3,中科院一区)
[9] Hailong Liu#, Yonliang Sun, …, Yong-qiang Liu*, Xinguang Yu* and Shiyu Feng*. Pro-inflammatory and proliferative microglia drive progression of glioblastoma. Cell Reports, 2021, 36: 109718.(IF:9.4,中科院一区)
[10] Su-Fen Wei#, …, Qi Wang*, Yong-Qiang Liu*. Identification of pseudolaric acid B as a novel Hedgehog pathway inhibitor in medulloblastoma. Biochemical Pharmacology, 2021, 190: 114593.(IF:5.3,中科院二区)
[11] Xiang-Zhen Fan, Yu-Fei Chen, …, Hua-Feng Pan*, Yong-Qiang Liu*. Centipeda minima extract sensitizes lung cancer cells to DNA-crosslinking agents via targeting Fanconi anemia pathway. Phytomedicine, 2021, 91: 153689. (IF:5.3,中科院一区)
[12] Yong-Qiang Liu*, …, Yong-Xian Cheng*. Protection against chemotherapy- and radiotherapy-induced side effects: mechanisms and therapeutic opportunities of phytochemicals. Phytomedicine, 2021, 80: 153402.(IF:5.3,中科院一区,高被引论文)
[13] Yongqiang Liu#, Larra Yuelling#, …, Zeng-Jie Yang*. Astrocytes promote medulloblastoma progression through hedgehog secretion. Cancer Research, 2017, 77(23): 6692-6703. (IF 9.5,中科院一区)
其他代表性业绩
2024年度广东省传统医学会科技进步奖二等奖,鹅不食草及其成分增敏肺癌化疗的新策略,樊湘珍,潘华峰,刘永强,李伟,何佩瑶。